Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $47.39 million versus the consensus estimate of $47.08 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.